BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3265240)

  • 1. [Complement-binding antibodies in women simultaneously infected with various species of Trichomonas].
    Cvetkova A; Ishev V; Andreeva N
    Wiad Parazytol; 1988; 34(2):185-90. PubMed ID: 3265240
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of a crude extract or a purified antigen of Trichomonas vaginalis for the detection of secretory antibodies by ELISA.
    Angeretti A; Merlino C; Savoia D; Martinotti MG
    Microbiologica; 1988 Jan; 11(1):29-35. PubMed ID: 3258398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of polysaccharide and glycoprotein fractions of Trichomonas vaginalis in the serodiagnosis of Trichomonas infections].
    Małyszko E; Januszko T; Ustymowicz-Farbiszewska J; Czapska D
    Wiad Parazytol; 1991; 37(2):225-33. PubMed ID: 1822039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic importance of the complement fixation test for the demonstration of Trichomonas vaginalis infections].
    Philipp G; Jankó M
    Zentralbl Gynakol; 1970 Apr; 92(15):465-8. PubMed ID: 4930753
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-reactivity of Trichomonas in cervical p16INK4a immunocytochemistry is dependent on antibody, not antigen.
    Ridder R; Trunk MJ; Negri G
    Diagn Cytopathol; 2006 Jul; 34(7):512-4; author reply 515. PubMed ID: 16783782
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Trichomonas vaginalis alpha-actinin as the most common immunogen recognized by sera of women exposed to the parasite.
    Addis MF; Rappelli P; Pinto De Andrade AM; Rita FM; Colombo MM; Cappuccinelli P; Fiori PL
    J Infect Dis; 1999 Nov; 180(5):1727-30. PubMed ID: 10515842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antitrichomonal antibodies in sera and cervical secretions in trichomoniasis.
    Romia SA; Othman TA
    J Egypt Soc Parasitol; 1991 Aug; 21(2):373-81. PubMed ID: 1875069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of phagocytosis in experimental Trichomonas vaginalis infection in mice].
    Poli G; Cappuccinelli P; Sena L; Longhin PP
    Boll Soc Ital Biol Sper; 1974 Oct; 50(20):1680-3. PubMed ID: 4549427
    [No Abstract]   [Full Text] [Related]  

  • 9. Trichomonas tenax in haemodyalized patients--serologic research.
    Ioli A; Ferlazzo M; Fossari MT; Gembillo C; Skotarczak B; Vasi A; Verzera A; Torre F; Mallamace A; Bellinghieri G
    Wiad Parazytol; 1987; 33(2):165-7. PubMed ID: 3687008
    [No Abstract]   [Full Text] [Related]  

  • 10. [The induction and disappearance of complement-fixing antibodies in the blood serum of experimental animals under the antigenic action of Trichomonas vaginalis, T. hominis and T. tenax].
    Ellamaa MKh; Ryĭgas EM
    Parazitologiia; 1979; 13(1):65-70. PubMed ID: 95819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of trichomonal antigens by means of complement fixation].
    Iankov N; Baltova E; Ishev V; Angelova E
    Akush Ginekol (Sofiia); 1972; 11(5):450-2. PubMed ID: 4539896
    [No Abstract]   [Full Text] [Related]  

  • 12. Proteinases of Trichomonas vaginalis: antibody response in patients with urogenital trichomoniasis.
    Bózner P; Gombosová A; Valent M; Demes P; Alderete JF
    Parasitology; 1992 Dec; 105 ( Pt 3)():387-91. PubMed ID: 1461679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of trichomonads antigen in trichomoniasis].
    Korik LM
    Vestn Dermatol Venerol; 1966 Jan; 40(1):50-5. PubMed ID: 5974384
    [No Abstract]   [Full Text] [Related]  

  • 14. Cysteine proteinase 30 (CP30) and antibody response to CP30 in serum and vaginal washes of symptomatic and asymptomatic Trichomonas vaginalis-infected women.
    Yadav M; Dubey ML; Gupta I; Malla N
    Parasite Immunol; 2007 Jul; 29(7):359-65. PubMed ID: 17576365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cloning, expression and immunogenicity analysis of cysteine proteinase 3 of Trichomonas vaginalis].
    Jia WZ; Li Z; Zhao L; Nie FF; Lun ZR
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Dec; 27(6):483-7. PubMed ID: 20232629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the ELISA method in the determination of antibodies to Trichomonas vaginalis].
    Gombosová A; Valent M
    Bratisl Lek Listy; 1988 Sep; 89(9):689-93. PubMed ID: 3264749
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative study of epitopes recognized by two monoclonal antibodies that protects mice against Trichomonas vaginalis challenge.
    Hernández H; Marcet R; Figueredo M; Garrido N; Sarracent J
    Exp Parasitol; 2008 Apr; 118(4):583-6. PubMed ID: 18031741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary study on the relationship between Trichomonas vaginalis and cervical cancer in Egyptian women.
    Sayed el-Ahl SA; el-Wakil HS; Kamel NM; Mahmoud MS
    J Egypt Soc Parasitol; 2002 Apr; 32(1):167-78. PubMed ID: 12049252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indirect immunofluorescence in the serodiagnosis of Trichomonas vaginalis infections].
    Sangiorgio M; Barbuto Attiè MC; Granucci E; Ghione M
    Boll Ist Sieroter Milan; 1987; 66(1):55-8. PubMed ID: 3304346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the population density of T. vaginalis Donné in cultures with fungi strains isolated from cases of trichomonadosis or trichomonadosomycosis].
    Kurnatowska A; Horwatt E
    Wiad Parazytol; 1977; 23(5):529-33. PubMed ID: 305164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.